RBC Capital Maintains Outperform on Medpace Holdings, Lowers Price Target to $484

Benzinga Newsdesk www.benzinga.com Negative 95.0%

Neg 95% Neu 0% Pos 0%

RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $522 to $484.